Valneva SE (VALN) Enterprise Value (2019 - 2026)
Valneva SE (VALN) posted quarterly Enterprise Value of -$119.8 million for Q1 2026, up 31.19% year-on-year from -$91.3 million in Q1 2025, and up 4.0% on a QoQ basis from -$124.8 million in Q4 2025.
Valneva SE (VALN) Enterprise Value (2019 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Enterprise Value for 8 consecutive years, with -$119.8 million the latest figure, recorded in Q1 2026.
- Quarterly Enterprise Value rose 31.19% year-over-year to -$119.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$119.8 million (up 31.19% YoY) and the FY2025 annual result came in at -$124.8 million, up 35.32% from the prior year.
- Enterprise Value improved to -$119.8 million in Q1 2026 per VALN's latest filing, from -$124.8 million in the prior quarter.
- Over the last five years, Enterprise Value for VALN reached as high as -$119.8 million in Q1 2026 and fell as low as -$382.6 million in Q2 2022.
- A 5-year average of -$218.2 million and a median of -$192.9 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value sank 716230.0% — and 2023, when it surged 55.61%.
- Year by year, Enterprise Value stood at -$326.1 million in 2022, then jumped by 55.61% to -$144.7 million in 2023, then tumbled by 33.29% to -$192.9 million in 2024, then jumped by 35.32% to -$124.8 million in 2025, then rose by 4.0% to -$119.8 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$119.8 million, -$124.8 million, and -$163.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | -119.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -119.79 Mn |
| Dec 31, 2025 | -124.78 Mn |
| Sep 30, 2025 | -163.25 Mn |
| Jun 30, 2025 | -185.05 Mn |
| Mar 31, 2025 | -174.10 Mn |
| Dec 31, 2024 | -192.91 Mn |
| Sep 30, 2024 | -177.90 Mn |
| Jun 30, 2024 | -149.54 Mn |
| Mar 31, 2024 | -201.01 Mn |
| Dec 31, 2023 | -144.74 Mn |
| Sep 30, 2023 | -194.88 Mn |
| Jun 30, 2023 | -232.61 Mn |
| Mar 31, 2023 | -289.59 Mn |
| Dec 31, 2022 | -326.06 Mn |
| Sep 30, 2022 | -297.05 Mn |
| Jun 30, 2022 | -382.61 Mn |
| Mar 31, 2022 | -354.20 Mn |
| Dec 31, 2021 | -45,518.17 |
| Sep 30, 2021 | -282.15 Mn |
| Jun 30, 2021 | -375.30 Mn |